Histone Organization

Slide 1 · Histone Organization

Chromatin architecture, epigenetic regulation and related gene-control mechanisms

Robbins, Cotran & Kumar · Pathologic Basis of Disease · 11th edition

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Describe the nucleosome, histone octamer and linker DNA.

Relate euchromatin and heterochromatin to transcriptional accessibility.

Explain chromatin remodeling and the functions of writers, readers and erasers.

Connect reversible epigenetic regulation with disease and treatment.

Distinguish chromatin control from miRNA, lncRNA and CRISPR mechanisms.

Slide 3 · Three molecular levels of gene control

DNA sequence

Chromatin accessibility

RNA-level control

Protein output

Slide 4 · Identical genome, different cell identities

Same DNA

Sequence

Lineage-specific chromatin state

Cell type A

Program A

Cell type B

Program B

Cell type C

Program C

Different phenotypes arise from selective gene expression—not a different genome.

Slide 5 · Epigenetic factors: Regulation above DNA sequence

Core concept

Differentiated cells share nearly the same genetic composition.

Cell-type identity depends on lineage-specific gene-expression programs.

Epigenetic mechanisms alter the use of DNA without requiring sequence change.

Why it matters

Chromatin state contributes to selective transcription and cellular phenotype.

Slide 6 · Transcription is not dictated by DNA sequence alone

Promoters and enhancers encode regulatory potential.

Nucleosome position determines whether regulatory sites can be accessed.

Histone modifications and chromatin organizers add another regulatory layer.

Distinction

DNA sequence defines possible interactions; Chromatin affects physical access.

Slide 7 · The physical DNA-packaging problem

~1.8 m

DNA in a single human cell

~7–8 µm

Nucleus

Packaging makes the genome physically compatible with nuclear dimensions.

Slide 8 · Why DNA binds histone proteins

DNA backbone

Negative charge (−)

Histone proteins

Positive charge (+)

Electrostatic association

Slide 9 · Nucleosome: The repeating unit of chromatin

Histone octamer

DNA wound around core

Schematic; Core DNA: 147 base pairs.

Slide 10 · The histone core is an octamer

H2A × 2

H2B × 2

H3 × 2

H4 × 2

Two copies each of H2A, H2B, H3 and H4 form the octamer.

Slide 11 · The core wraps 147 base pairs of DNA

Nucleosomal DNA

A nucleosome core contains approximately 147 bp of DNA.

DNA winds around a positively charged histone octamer.

This repeating structure compacts DNA while permitting regulation.

Remember

147 bp describes the DNA wrapped on the core—not the linker.

Slide 12 · Linker DNA and histone H1

Core DNA: 147 bp

Linker DNA: ~20–80 nt

H1 on linker

H1 is a linker histone, distinct from the H2A/H2B/H3/H4 core octamer.

Slide 13 · Chromatin as a beads-on-a-string fiber

Repeated nucleosomes are linked by short DNA segments—the “beads on a string” model.

Slide 14 · Compaction and transcriptional access are coupled

Packaging

DNA–histone association allows a very long genome to fit within the nucleus.

Regulation

Local remodeling and histone marks modulate access to regulatory DNA.

Slide 15 · Chromatin is not uniformly condensed

Euchromatin

Heterochromatin

Left: Dispersed chromatin; Right: Condensed, intensely stained chromatin. Schematic only.

Slide 16 · Euchromatin: Dispersed, transcriptionally active

Relatively open chromatin in the light-microscopic nucleus.

Genes in these regions are generally more available for transcription.

Histone marks supporting access to RNA polymerase are common.

Microscopy

Less densely stained nuclear regions correspond broadly to euchromatin.

Slide 17 · Heterochromatin: Condensed, transcriptionally inactive

Relatively dense chromatin identifiable at light microscopy.

Compaction reduces access to regulatory sequences and transcription machinery.

Chromatin-associated marks help maintain gene silencing.

Microscopy

More intense nuclear staining reflects a compact chromatin state.

Slide 18 · Euchromatin versus heterochromatin

Feature

Euchromatin

Heterochromatin

Organization

More dispersed

More condensed

Typical transcription

More active

More inactive

Regulatory access

More accessible

More restricted

Light microscopy

Less dense regions

Dense chromatin regions

Slide 19 · What chromatin pattern reveals in a nucleus

A light-microscopic image shows spatial organization of chromatin.

The euchromatin–heterochromatin distinction is a useful structural approximation.

Transcriptional status cannot be fully inferred from a single nuclear image.

Interpretation

Morphology suggests chromatin state; It does not identify the exact gene program.

Slide 20 · Access to DNA determines transcriptional opportunity

Accessible region

Regulatory DNA exposed

Compact region

Regulatory DNA obscured

A simplified illustration of relative nucleosome density and DNA access.

Slide 21 · Regulatory DNA must be physically accessible

Promoters are docking regions for the transcription apparatus.

Enhancers can influence transcription when appropriately positioned.

Nucleosomes can expose or conceal these regulatory elements.

Mechanism

Chromatin remodeling changes promoter/enhancer accessibility without changing the DNA letters.

Slide 22 · Chromatin-remodeling complexes move nucleosomes

Remodeling complexes reposition nucleosomes along DNA.

Relocation can expose a formerly obstructed regulatory element.

Relocation can also hide an element and suppress transcription.

Key distinction

A remodeling complex primarily changes nucleosome position, not DNA sequence.

Slide 23 · Nucleosome repositioning changes promoter exposure

Initially hidden promoter

Remodeling complex

Promoter exposed

Nucleosome repositioning can obscure or reveal cis-regulatory DNA.

Slide 24 · Writers, readers and erasers of histone marks

Writers

Place modifications

Readers

Bind selected marks

Erasers

Remove modifications

Regulatory outcome depends on which residue is modified and which protein recognizes it.

Slide 25 · Histone marks are dynamic regulatory signals

More than 70 types of histone modification.

Different marks are placed on particular histone amino-acid residues.

The meaning of a mark depends on its position and protein context.

Avoid oversimplification

A “histone mark” does not invariably mean activation or repression.

Slide 26 · Three major classes of histone modification

Acetylation

Lysine

Methylation

Lysine / arginine

Phosphorylation

Serine

Modification identity alone does not specify the direction of gene expression.

Slide 27 · Histone acetylation favors accessible chromatin

Histone acetyltransferases (HATs) acetylate lysine residues.

Acetylation tends to promote an open chromatin configuration.

Such regions are generally more permissive to transcription.

Typical effect

Acetylation → relaxed chromatin tendency → more transcriptional access.

Slide 28 · Histone acetyltransferases: Adding acetyl groups

Histone lysine tail

Histone acetyltransferase

Acetylated chromatin

More accessible

Typical tendency: Increased transcription

Slide 29 · Histone deacetylases reverse lysine acetylation

Histone deacetylases (HDACs) remove acetyl modifications.

Deacetylation generally favors chromatin condensation.

Acetylation state is consequently a potentially reversible regulatory feature.

Typical effect

HDAC activity → lower acetylation → more compact chromatin tendency.

Slide 30 · Acetylation and deacetylation are reversible

Lysine acetylation

HAT

Lysine deacetylation

HDAC

Open chromatin tendency

Condensed chromatin tendency

These are tendencies, not universal on/off switches for every gene.

Slide 31 · Histone methylation has context-dependent effects

Specific enzymes methylate histone lysine or arginine residues.

Histone lysine methylation can be associated with activation or silencing.

The particular marked residue determines much of the interpretation.

Exam pitfall

Do not equate every methyl group on a histone with gene repression.

Slide 32 · Methylation is not a universal off switch

One histone residue

Methylation may contribute to a transcriptionally active chromatin state.

Another histone residue

Methylation may instead promote condensed, silent chromatin.

The source emphasizes residue specificity; It does not provide a universal list of named sites.

Slide 33 · Histone phosphorylation can support different states

Phosphate groups may be added to selected serine residues.

The associated chromatin may become more accessible or more condensed.

Functional significance depends on the residue and context.

Concept

“Phosphorylation” specifies a chemical mark—not a fixed transcriptional outcome.

Slide 34 · Compare histone modifications

Modification

Target residue

Effect

Acetylation

Lysine

Usually more accessible chromatin

Methylation

Lysine or arginine

Activation or repression, site-dependent

Phosphorylation

Serine

Access or condensation, site-dependent

Slide 35 · DNA methylation is a separate regulatory layer

DNA regulatory element

High DNA methylation

Transcriptional silencing

(typical)

Contrast: Histone methylation may either activate or repress transcription.

Slide 36 · DNA methylation has its own regulators

DNA methyltransferases place methyl marks on DNA.

Demethylating enzymes help reverse such modifications.

Methylated-DNA-binding proteins recognize selected methylated sites.

Usual result

High methylation of regulatory elements commonly accompanies transcriptional silencing.

Slide 37 · Histone methylation is not DNA methylation

Feature

Histone methylation

DNA methylation

Modified substrate

Histone amino-acid residues

DNA

Common outcome

Activation or repression

Regulatory-element methylation usually silences

Regulators

Histone writer/reader/eraser systems

DNA methyltransferases and demethylating systems

Slide 38 · Chromatin looping brings distant elements together

Enhancer

Promoter

3D looping juxtaposes distant DNA elements

Conceptual only: Spatial regulation depends on chromatin-organizing proteins.

Slide 39 · Chromatin organizers modulate 3D DNA relationships

Chromatin-organizing factors bind noncoding genomic regions.

DNA looping can bring enhancers into functional proximity with promoters.

Spatial genome organization adds regulation beyond local histone marks.

Limits

The Robbins chapter explicitly notes that these organizing factors remain incompletely characterized.

Slide 40 · Cell-type gene expression emerges from several levels

DNA regulatory

Sequences

Nucleosome position

& histone marks

Chromatin architecture

& looping

Lineage-specific

Transcription

No single chromatin modification can explain all cell-specific gene-expression patterns.

Slide 41 · Epigenetic dysregulation and malignancy

Altered

Epigenome

Abnormal gene

Expression programs

Malignancy

Association

Epigenome dysregulation as a central feature in malignant disease.

Slide 42 · Epigenetic changes may be inherited or acquired

Altered epigenetic regulation can occur without changing protein-coding DNA sequence.

Epigenetic abnormalities to malignant disease.

Inherited and acquired epigenetic changes are also implicated in other diseases.

Distinction

Epigenetic mechanisms are separate from—but interact with—genetic mutations.

Slide 43 · Reversibility provides a therapeutic rationale

Histone acetylation and DNA methylation are modifiable chemical states.

Some epigenetic alterations are therefore amenable to pharmacologic intervention.

DNA methylation inhibitors are used in cancer treatment, as.

Clinical principle

Targeting a reversible chromatin regulator may restore or alter gene expression.

Slide 44 · Histone organization: Mechanism recap

Physical substrate

DNA is wrapped around a histone octamer; H1 associates with linker DNA.

Regulatory state

Accessible euchromatin contrasts with condensed heterochromatin.

Dynamic control

Remodelers and histone-mark writers/readers/erasers govern DNA access.

Clinical link

Epigenome disruption is implicated in malignancy and is potentially druggable.

Slide 45 · Application: Interpreting nuclear chromatin

Two differentiated cells have the same genomic DNA sequence. One shows more dispersed nuclear chromatin and expresses a lineage-specific gene panel.

Consider

What structural feature could help explain the expression difference?

Why would different promoter sequences not be necessary?

Slide 46 · Application: Blocking an epigenetic enzyme

A compound decreases the activity of a histone deacetylase in a model cell line.

Consider

What happens to the acetylation–deacetylation balance?

What general change in chromatin access would be expected?

Why does that not guarantee activation of every gene?

Slide 47 · Noncoding RNAs extend gene regulation beyond chromatin

MicroRNAs (miRNAs)

Short noncoding RNAs that guide post-transcriptional silencing of target mRNAs.

Long noncoding RNAs (lncRNAs)

Long transcripts with diverse regulatory effects, including chromatin and transcriptional control.

Slide 48 · MicroRNAs modulate protein expression

MiRNAs are small RNAs, averaging about 22 nucleotides.

They do not encode proteins.

By pairing with target mRNAs, they can reduce translation or favor mRNA cleavage.

Regulatory stage

MiRNAs act primarily after transcription, whereas histone marks affect access for transcription.

Slide 49 · Biogenesis of an active microRNA

MiRNA gene

Primary transcript

Dicer processing

Mature miRNA

RISC

Slide 50 · Dicer helps produce mature regulatory RNAs

MiRNA genes are transcribed into a primary precursor (pri-miRNA).

Progressive processing includes cleavage by the enzyme Dicer.

Mature miRNA strands are about 21–30 nucleotides and associate with RISC.

Important term

RISC = RNA-induced silencing complex.

Slide 51 · RISC targets messenger RNA

Mature miRNA

RISC

Target mRNA

MRNA cleavage

Translation repression

MiRNA–mRNA base pairing guides post-transcriptional gene silencing.

Slide 52 · One microRNA can affect many protein-coding genes

A single miRNA can recognize multiple mRNA targets.

Consequently, one miRNA can coregulate a broad expression program.

This contributes to developmental control and disease states, including cancer.

Systems effect

Target multiplicity links short RNAs to network-scale changes in protein expression.

Slide 53 · Synthetic siRNAs provide experimental gene knockdown

Small interfering RNAs (siRNAs) can be introduced into cells.

The source describes their use of Dicer/RISC-related machinery.

Designed siRNAs permit reduction of expression from selected mRNA targets.

Research application

Knockdown changes transcript abundance or translation without editing the DNA sequence.

Slide 54 · SiRNA technology also has therapeutic applications

Synthetic siRNAs can target excessive or inappropriate gene function.

Approved therapeutic applications.

Selected forms of amyloidosis are given as an example.

Boundary

RNA interference is not equivalent to CRISPR DNA editing.

Slide 55 · Long noncoding RNAs can regulate chromatin

LncRNAs are non-protein-coding transcripts longer than 200 nucleotides.

Some lncRNAs associate with chromatin and limit RNA polymerase access.

Other lncRNAs can enhance gene transcription through distinct mechanisms.

Difference from miRNAs

LncRNAs may operate at the chromatin or transcription level, rather than chiefly on mature mRNA.

Slide 56 · XIST mediates X-chromosome inactivation

X chromosome

Before silencing

XIST-coated X

Repressed

XIST lncRNA acts in cis to establish a repressive environment on its chromosome.

Slide 57 · XIST provides a physiological silencing example

XIST is transcribed from the X chromosome and escapes its inactivation.

Its transcript spreads as a repressive “cloak” over the source X chromosome.

The resulting chromatin environment supports chromosome-scale gene silencing.

Principle

A noncoding RNA can alter expression across an entire chromosomal domain.

Slide 58 · Enhancer-associated lncRNAs may increase transcription

Some enhancer loci produce long noncoding RNA transcripts.

These transcripts can participate in positive regulation of gene promoters.

The source emphasizes diversity rather than one universal mechanism.

Contrast

LncRNA activity can be activating or repressive depending on its context.

Slide 59 · MiRNA and lncRNA: Different regulatory strategies

Property

MicroRNA

Long noncoding RNA

General size

~22 nt on average

>200 nt

Main examples here

MRNA targeting through RISC

Chromatin silencing; Enhancer effects

Functional scope

Post-transcriptional repression

Variable transcriptional regulation

Slide 60 · CRISPR–Cas originated in microbial defense

CRISPR sequences and Cas genes function in prokaryotic defense.

Bacteria retain sequence information from invading genetic elements.

Guide RNAs then help Cas proteins recognize matching targets.

Origin

Genome editing adapts a naturally occurring sequence-recognition and cleavage system.

Slide 61 · The natural CRISPR defense concept

Foreign phage or

Plasmid DNA

Sequence captured

As CRISPR information

Guide RNA

Produced

Cas nuclease targets

Matching foreign DNA

Simplified conceptual sequence from the Robbins section.

Slide 62 · Engineered CRISPR–Cas9 editing

Guide RNA

~20-base target match

Cas9 nuclease

Target DNA

Double-strand break

Simplified CRISPR–Cas9 editing mechanism.

Slide 63 · Guide RNA defines the target sequence

An engineered guide RNA is complementary to a selected DNA sequence.

An approximately 20-base guide targeting segment.

Guide RNA directs Cas9 to the corresponding genomic site.

Editing step

Target recognition precedes DNA cleavage by Cas9.

Slide 64 · DNA repair determines the editing outcome

Cas9 DNA cleavage

Nonhomologous end joining

Homology-directed repair

Often disruptive indels

Precise sequence change with template

Random disruptive mutations versus precise introduction of genetic material.

Slide 65 · Repair mechanisms after Cas9 cleavage

Pathway

Mechanism

Typical editing result

Nonhomologous end joining

Rejoin broken DNA ends

Potentially disruptive mutations

Homology-directed repair

Use a homologous donor sequence

Precisely introduced DNA change

Slide 66 · Gene editing is a tool for disease modelling

Targeted mutations can be introduced in cells or tissues.

Edited cells can model cancer and other disease mechanisms.

Transgenic animal models can be generated from edited stem cells.

Research value

The approach probes causal consequences of sequence changes.

Slide 67 · CRISPR has entered treatment of inherited disease

Therapeutic application in inherited disorders.

Sickle cell disease is an example cited in the chapter.

Clinical deployment must be distinguished from experimental uses.

Clinical boundary

A gene-editing intervention changes DNA; Epigenetic therapies alter reversible regulatory states.

Slide 68 · Genome editing also raises ethical questions

Sequence modification can be used for laboratory research and clinical intervention.

Potential use to alter non-disease-associated traits raises ethical concerns.

Robbins explicitly identifies a vigorous debate about these applications.

Scope

Evaluate intended use, affected cells and consequences—rather than treating all editing as equivalent.

Slide 69 · Compare levels of intervention in gene regulation

Chromatin

DNA access for transcription

MiRNA / lncRNA

RNA-mediated gene regulation

CRISPR–Cas9

Intentional alteration of DNA sequence

Slide 70 · Case: Identify the regulatory mechanism

A cell maintains the same DNA sequence but changes transcription after nucleosomes are repositioned away from a promoter. A second experiment depletes a target mRNA using an introduced short RNA.

Consider

Which experiment changes chromatin accessibility?

Which intervention acts at the RNA level?

Does either require changing the genomic sequence?

Slide 71 · Case: Explain a targeted DNA modification

An investigator delivers Cas9 and an engineered guide RNA. A double-strand break is produced at the targeted genomic site.

Consider

What is the guide RNA’s function?

Which repair route commonly yields disruptive mutations?

Which route can install donor-encoded sequence?

Slide 72 · Synthesis: Principles to retain

Nucleosomes

147 bp of DNA around a core octamer, with H1 associated with linker DNA.

Chromatin state

Euchromatin is generally accessible; Heterochromatin is condensed and silent.

Epigenetic marks

Acetylation generally opens; Methylation and phosphorylation are site-dependent.

Other regulators

MiRNAs and lncRNAs influence gene expression; Cas9 can directly alter DNA.

Slide 73 · References and source boundaries

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th ed. (2026). Chapter 1, “The Cell as a Unit of Health and Disease,” pp. 3–5.

Primary sections: Histone Organization; MicroRNA and Long Noncoding RNA; MicroRNA; Long Noncoding RNA; Gene Editing.

All molecular schematics in this presentation are original, editable teaching diagrams; they are not reproduced textbook figures.